Current protocolsCapsid ProteinsEscherichia coliVaccinesVirus-Like ParticleCost-Benefit Analysis
Rapid, Scalable, and Cost-Effective Manufacturing of Uniform Non-Enveloped, Tag-Free Virus-Like Particles.
Xiaoyan Wang, Yanhao Gu, Hong Luo, Cinderella Nowak, Rui Chen, Yue Hui, Sha Liu, Lukas Gersweller
Published: 202610.1002/cpz1.70309
Abstract
Virus-like particles (VLPs) are widely recognized as safe and versatile nanostructures with broad applications in vaccine development, gene delivery, and nanotechnology, but their production typically requires time-consuming procedures, incurs high c…
Preview only. Read the full abstract at the source